This company has shut down. Tarveda Therapeutics is no longer operating — its last tracked round was a Venture - Series Unknown in 2021.
Explore the Startup GraveyardTarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Tarveda Therapeutics has raised $6.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2021.
Tarveda Therapeutics's investors include New Enterprise Associates, Versant Ventures, Novo Holdings, Flagship Pioneering, +ND Capital.
Tarveda Therapeutics is headquartered in Watertown, United States.
Tarveda Therapeutics is a developer of miniature drug conjugates designed for the treatment of patients with a wide range of solid tumors.
Tarveda Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Tarveda Therapeutics — Funding & Investors." VCBacked, September 27, 2021, https://www.vcbacked.co/company/tarveda-therapeutics. Accessed August 7, 2026.
VCBacked. (2021). Tarveda Therapeutics — Funding & Investors. Retrieved August 7, 2026, from https://www.vcbacked.co/company/tarveda-therapeutics
{{cite web |title=Tarveda Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/tarveda-therapeutics |website=VCBacked |access-date=August 7, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated